Nephros (NEPH) Share-based Compensation (2010 - 2026)
Nephros (NEPH) posted quarterly Share-based Compensation of $60000.0 for Q1 2026, down 21.05% year-over-year from $76000.0 in Q1 2025, and down 27.71% quarter-over-quarter from $83000.0 in Q4 2025.
Nephros (NEPH) Share-based Compensation (2010 - 2026) Analysis & Trends
Nephros' Share-based Compensation history runs 17 years deep, the most recent figure standing at $60000.0 for Q1 2026.
- In Q1 2026, Share-based Compensation fell 21.05% year-over-year to $60000.0; the TTM figure through Mar 2026 stood at $228000.0 (up 50.99% YoY), while the FY2025 annual figure was $400000.0, up 300.0% from the prior year.
- Share-based Compensation for Q1 2026 stood at $60000.0, down from $83000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $913000.0 in Q4 2022, with the low at -$9000.0 in Q1 2024.
- The 5-year median for Share-based Compensation is $83000.0 (2025), against an average of $214117.6.
- The sharpest annual moves came in 2024 and 2025: Share-based Compensation plunged 102.82% in 2024, then jumped 23950.0% in 2025.
- Nephros' Share-based Compensation stood at $913000.0 in 2022, then sank by 45.02% to $502000.0 in 2023, then plunged by 98.21% to $9000.0 in 2024, then jumped by 822.22% to $83000.0 in 2025, then slipped by 27.71% to $60000.0 in 2026.
- Business Quant data shows NEPH's Share-based Compensation at $60000.0 in Q1 2026, $83000.0 in Q4 2025, and $451000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.89 Bn | 127.67 Bn | 1.96 Bn | 67.10 Mn |
| 2 | Becton Dickinson | 51.87 Bn | 51.01 Bn | 2.32 Bn | 55.00 Mn |
| 3 | Alcon | 35.51 Bn | 34.16 Bn | 1.68 Bn | 42.00 Mn |
| 4 | Resmed | 33.52 Bn | 32.06 Bn | 861.22 Mn | 27.46 Mn |
| 5 | Medline | 28.31 Bn | 25.63 Bn | 2.22 Bn | 29.00 Mn |
| 6 | West Pharmaceutical Services | 24.97 Bn | 24.53 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Solventum | 15.26 Bn | 14.86 Bn | 1.29 Bn | 38.00 Mn |
| 8 | Cooper Companies | 14.84 Bn | 14.70 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.57 Bn | 11.42 Bn | 1.03 Bn | 33.00 Mn |
| 10 | Nephros | 46.14 Mn | 41.44 Mn | 4.03 Mn | 346,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 346,000.00 |
| Jun 30, 2026 | 346,000.00 |
| Mar 31, 2026 | 60,000.00 |
| Mar 31, 2026 | 60,000.00 |
| Dec 31, 2025 | 83,000.00 |
| Dec 31, 2025 | 83,000.00 |
| Sep 30, 2025 | 451,000.00 |
| Sep 30, 2025 | 451,000.00 |
| Jun 30, 2025 | 481,000.00 |
| Jun 30, 2025 | 481,000.00 |
| Mar 31, 2025 | 76,000.00 |
| Mar 31, 2025 | 76,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | 64,000.00 |
| Sep 30, 2024 | 64,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | -9,000.00 |
| Mar 31, 2024 | -9,000.00 |